ArticleBritish journal of haematology2026
BCL-2 and MCL1 co-inhibition enhances glucocorticoid therapy in preclinical models of infant KMT2A-rearranged acute lymphoblastic leukaemia.
Mawar Karsa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.